In a welcome move, MaxLinear saw its Relative Strength Rating rise from 70 to 78 on Friday.
Can You Really Time The Stock Market?
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the top-performing stocks often have an RS Rating north of 80 in the early stages of their moves. See if MaxLinear can continue to show renewed price strength and hit that benchmark.
While MaxLinear is not near a proper buy point right now, see if it goes on to form and break out of a proper consolidation.
MaxLinear reported 0% EPS growth last quarter. Sales rose 18%.
MaxLinear holds the No. 17 rank among its peers in the Electronics-Semiconductor Fabless industry group. Astera Labs, Broadcom and Credo Tech Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Chip Stocks To Watch And Semiconductor Industry News
IBD Stock Rating Upgrades: Rising Relative Strength
